Edward Stelmakh
2021
In 2021, Edward Stelmakh earned a total compensation of $3.2M as Chief Financial Officer & Chief Operating Officer at OptimizeRx Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $72,071 |
|---|---|
| Option Awards | $1,000,020 |
| Salary | $96,715 |
| Stock Awards | $2,000,004 |
| Total | $3,168,810 |
Stelmakh received $2M in stock awards, accounting for 63% of the total pay in 2021.
Stelmakh also received $72.1K in non-equity incentive plan, $1M in option awards and $96.7K in salary.
Rankings
In 2021, Edward Stelmakh's compensation ranked 4,224th out of 12,415 executives tracked by ExecPay. In other words, Stelmakh earned more than 66.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,224 out of 12,415 | 66th |
Division Services | 1,024 out of 2,290 | 55th |
Major group Business Services | 696 out of 1,533 | 55th |
Industry group Miscellaneous Business Services | 120 out of 266 | 55th |
Industry Business Services, Not Elsewhere Classified | 109 out of 236 | 54th |
Source: SEC filing on April 25, 2022.
Stelmakh's colleagues
We found three more compensation records of executives who worked with Edward Stelmakh at OptimizeRx Corp in 2021.